Jove
Visualize
联系我们

相关概念视频

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Biopharmaceutical Factors Influencing Drug Product Design: Overview01:22

Biopharmaceutical Factors Influencing Drug Product Design: Overview

Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
FDA Approved Drugs: Changes to Approved Drugs01:26

FDA Approved Drugs: Changes to Approved Drugs

Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A Licensure Framework for Autonomous Clinical AI.

JAMA·2026
Same author

A randomized control trial of re-designed and shorter research informed consent forms to improve comprehension.

Clinical trials (London, England)·2026
Same author

A Machine Learning Model to Improve Risk Adjustment Accuracy in Medicare.

Health services research·2026
Same author

The paradox of trust in health care in the age of social media.

Lancet (London, England)·2026
Same author

Human-AI teaming to improve accuracy and efficiency of eligibility criteria prescreening for oncology trials: a randomized evaluation trial using retrospective electronic health records.

Nature communications·2026
Same author

Policy Agenda to Close the Hypertension Gap.

Journal of the American College of Cardiology·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Jun 6, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

基于专利的制药开发过程:理由,问题和潜在的改革

John H Barton1, Ezekiel J Emanuel

  • 1Department of Clinical Bioethics, National Institutes of Health, Bethesda, Md 20892-1156, USA.

JAMA
|October 27, 2005
PubMed
概括

目前用于药物开发的专利制度限制了获取并错误分配了资源. 诸如分层定价和增加公共资金之类的改革可以改善药物可访问性和创新性.

科学领域:

  • 制药行业 制药行业 制药行业
  • 卫生经济学 卫生经济学
  • 药物发展政策 药物发展政策

背景情况:

  • 制药行业在药品定价,获取和研究优先事项方面面临批评.
  • 关于目前基于专利的药物开发系统的价值和公平性存在根本问题.
  • 问题包括金融障碍,高利和资源分配不当.

研究的目的:

  • 批判性地评估现有的药物开发专利体系.
  • 确定影响药物可访问性和创新的当前系统中的重大问题.
  • 为一个更公平,更有效的制度提出潜在的解决方案和补充性改革.

主要方法:

  • 分析制药行业的专利制度及其相关批评.
  • 确定目前基于专利的药物开发模式的六个主要问题.
  • 将潜在的解决方案分类为定价,行业结构和发展激励措施.

主要成果:

  • 专利制度可能会阻碍药物获取,扭曲研究重点以满足市场需求,并导致资源分配不当.
  • 该系统可能会导致相对于利而言,研究和开发的整体投资不足.
  • 现有的问题包括市场失败和对某些患者群体的歧视.
关键词:
分析方法 分析方法生物医学和行为研究研究.医疗保健和公共卫生

更多相关视频

Antibiotic Dereplication Using the Antibiotic Resistance Platform
10:49

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

Elucidation of the Material Basis of Yiqi Qingjie Formula Against IgA Nephropathy Using UHPLC-Q-Orbitrap HRMS Integrated with Network Pharmacology
08:44

Elucidation of the Material Basis of Yiqi Qingjie Formula Against IgA Nephropathy Using UHPLC-Q-Orbitrap HRMS Integrated with Network Pharmacology

Published on: May 19, 2026

相关实验视频

Last Updated: Jun 6, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Antibiotic Dereplication Using the Antibiotic Resistance Platform
10:49

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

Elucidation of the Material Basis of Yiqi Qingjie Formula Against IgA Nephropathy Using UHPLC-Q-Orbitrap HRMS Integrated with Network Pharmacology
08:44

Elucidation of the Material Basis of Yiqi Qingjie Formula Against IgA Nephropathy Using UHPLC-Q-Orbitrap HRMS Integrated with Network Pharmacology

Published on: May 19, 2026

结论:

  • 需要进行改革,以解决药品定价,行业结构和发展激励措施的问题.
  • 建议的改革包括批准后的比较测试,国际分层定价,增加政府资金和回购系统.
  • 在创新有限的条件下,建议针对性实验.